Stockscreener 앱 받기
1.12%
시간 외 거래:
전일 마감가:
$27.77
열려 있는:
$27.99
하루 거래량:
44.76M
Relative Volume:
1.01
시가총액:
$159.73B
수익:
$62.58B
순이익/손실:
$7.79B
주가수익비율:
20.72
EPS:
1.3551
순현금흐름:
$9.08B
1주 성능:
+4.15%
1개월 성능:
+1.56%
6개월 성능:
+10.20%
1년 성능:
+10.81%
1일 변동 폭
$27.79
$28.31
1주일 범위
$27.02
$28.31
52주 변동 폭
$20.91
$28.31
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE vs LLY, JNJ, ABBV, AZN, MRK
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
28.08 | 157.97B | 62.58B | 7.79B | 9.08B | 1.3551 |
LLY
Lilly Eli Co
|
919.77 | 792.08B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
244.44 | 584.06B | 94.19B | 26.80B | 19.70B | 11.05 |
ABBV
Abbvie Inc
|
217.49 | 376.96B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
197.22 | 300.68B | 58.80B | 10.24B | 8.98B | 3.2788 |
MRK
Merck Co Inc
|
120.29 | 291.99B | 64.93B | 18.26B | 12.36B | 7.2751 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-02 | 업그레이드 | Argus | Hold → Buy |
| 2026-02-25 | 개시 | RBC Capital Mkts | Underperform |
| 2026-02-20 | 개시 | Barclays | Underweight |
| 2026-02-12 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-02 | 재개 | Citigroup | Neutral |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Pfizer, Bain Must Litigate Cerevel Investors’ AbbVie Deal Suit - Bloomberg Law News
Pfizer to close South San Francisco research site (PFE:NYSE) - Seeking Alpha
Pfizer Inc. (NYSE:PFE) Tracks Healthcare Allocation In S&P 500 fund - Kalkine Media
Moderna, Pfizer Press to Toss Bayer’s Covid-Shot Patent Suits - Bloomberg Law News
Exclusive: Pfizer to shutter South S.F. research site, end Bay Area presence - San Francisco Chronicle
Is Pfizer Stock a Buy? Shares Hit Fresh High as Bulls and Bears Clash Over Valuation - TechStock²
Pfizer Inc Stock (PFE) Moved Up by 3.06% on Mar 31: Facts Behind the Movement - TradingKey
Pfizer Stock Edges Higher as Oncology Wins and Pipeline Bets Fuel Optimism Amid Flat 2026 Outlook - International Business Times Australia
Pfizer (NYSE:PFE) Hits New 1-Year HighWhat's Next? - MarketBeat
Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk - Barchart
Pfizer stock hits 52-week high at 27.99 USD By Investing.com - Investing.com Australia
Pfizer stock hits 52-week high at 27.99 USD - Investing.com
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - finance.yahoo.com
Pfizer Inc. $PFE Shares Purchased by QSM Asset Management Ltd - MarketBeat
Retirement Systems of Alabama Acquires 379,870 Shares of Pfizer Inc. $PFE - MarketBeat
U.S. Rivaroxaban Market Set to Boom Rapidly by 2033 | Pfizer Inc. • Merck & Co. • Amgen Inc - openPR.com
Mn Services Vermogensbeheer B.V. Boosts Position in Pfizer Inc. $PFE - MarketBeat
Is It Time To Reconsider Pfizer (PFE) After Diverging Valuation Narratives? - simplywall.st
Director at Pfizer (NYSE: PFE) receives phantom stock unit grant - Stock Titan
Pfizer (PFE) director Shantanu Narayen receives 1,849 Phantom Stock Units as deferred pay - Stock Titan
Pfizer (PFE) director Mortimer Buckley awarded 1,386.834 phantom units - Stock Titan
Pfizer says long-awaited Lyme vaccine was effective in study - UnionLeader.com
Pfizer (NYSE:PFE) Shares Up 2.6%Time to Buy? - MarketBeat
Pfizer's Post-2025 Strategy: Acquiring New GLP-1 Therapy After Internal SetbackNews and Statistics - IndexBox
Pharma Stocks Pfizer and GSK Provide Safe Investment Options Amid Market Uncertainty: Charts - Intellectia AI
Pfizer’s CAO on Building a Data and Process Foundation for AI - WSJ
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - finance.yahoo.com
Pfizer’s (PFE) Shares Up Since Jim Cramer Said “Pass” - Insider Monkey
Travelers Vaccines Market Set to Boom Rapidly, Witnessing - openPR.com
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline - Yahoo Finance Singapore
Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate - finance.yahoo.com
Pfizer Grant for Generic JAK Inhibitors in Rheumatology (USA) - fundsforNGOs
Pfizer (PFE) – Among the 15 Large Cap Stocks with Highest Dividends - Insider Monkey
Comirnaty Vaccine: Pfizer's Cornerstone COVID-19 Product Continues to Shape Global Health Markets in - AD HOC NEWS
Prediction: Buying Pfizer Stock Today Could Set You Up for Life - The Globe and Mail
Prediction: Buying Pfizer Stock Today Could Set You Up for Life - The Motley Fool
Pfizer Developments Draw Attention Across Market Benchmarks - Kalkine Media
Advisors Management Group Inc. ADV Sells 39,525 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Pfizer Oncology Wins Raise Questions On Valuation Gap And Future Revenues - simplywall.st
Pfizer Inc. Trade Ideas — BSESOF:PFE - TradingView
Lyme disease vaccine 70 percent effective: Pfizer - FOX 8 News
Wedge Capital Management L L P NC Grows Position in Pfizer Inc. $PFE - MarketBeat
A New Lyme Disease Vaccine Is In the Works - Women's Health
PFE Stock Quote Price and Forecast - CNN
Exchange Traded Concepts LLC Sells 60,810 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer (NYSE:PFE) Trading Down 2%Here's Why - MarketBeat
PFEPfizer Inc Stock Price and Quote - Finviz
Pfizer Options Spot-On: On March 27th, 99,614 Contracts Were Traded, With 2.42 Million Open Interest - Moomoo
Pfizer Inc. stock underperforms Friday when compared to competitors - MarketWatch
Pfizer: Why Wall Street Habitually Overestimates Target Price (NYSE:PFE) - Seeking Alpha
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
화이자 주식 (PFE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| LANKLER DOUGLAS M | Executive Vice President |
Feb 25 '26 |
Option Exercise |
33.82 |
122,907 |
4,156,715 |
282,186 |
| DAMICO JENNIFER B. | SVP & Controller |
Feb 25 '26 |
Option Exercise |
33.82 |
17,558 |
593,812 |
29,744 |
| BOURLA ALBERT | Chairman & CEO |
Feb 25 '26 |
Option Exercise |
33.82 |
491,626 |
16,626,791 |
864,215 |
| Fonseca Lidia | Executive Vice President |
Feb 25 '26 |
Option Exercise |
33.82 |
56,888 |
1,923,952 |
101,579 |
| McDermott Michael | Executive Vice President |
Feb 25 '26 |
Option Exercise |
33.82 |
37,925 |
1,282,624 |
114,534 |
4.14%
자본화:
|
볼륨(24시간):